Amin S. Herati, MD presented “iTIND: How I Do It” during the 2023 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on November 10, 2023, in Chicago, Illinois.
How to cite: Herati, Amin S. “iTIND: How I Do It” November, 2023. Accessed Aug 2024. https://grandroundsinurology.com/itind-how-i-do-it/
iTIND: How I Do It – Summary
Amin S. Herati, MD, provides an in-depth analysis of the implantation of the Temporary Implantable Nitinol Device (iTIND) for the treatment of benign prostatic hyperplasia (BPH). His discussion emphasizes the procedural details, benefits, and practical considerations of using iTIND, a minimally invasive therapy designed to relieve urinary symptoms associated with BPH.
Dr. Herati describes the indications for iTIND, highlighting its suitability for patients with moderate to severe BPH who are seeking alternatives to medication or more invasive surgical procedures. The procedural technique is meticulously detailed; Dr. Herati emphasizes the technical aspects critical to the procedure’s success, such as the precise placement of the device and careful monitoring during the implantation and removal processes.
The benefits of iTIND are highlighted, including its minimally invasive nature, rapid symptom relief, and preservation of sexual function. Additionally, the low incidence of complications, such as temporary dysuria and hematuria, is discussed. Challenges and limitations of iTIND are also addressed.
Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies.
